Latest stories

Top 5 Healthcare AI Moves in North Carolina Right Now

From a rare-disease data bet at UNC to Duke's heart-failure agent tests, these are the verified NC plays with dollars, names, and clear limits on what is, and is not, live in the clinic.

Duke Leads $15.5M ARPA-H SYMPHONY Consortium to Test Heart-Failure Agentic AI

The Durham-led award will evaluate and scale evidence for agentic AI in heart-failure care. It is not shipping an FDA-authorized product today.

NEXT Consortium kickoff in Durham this fall; first evaluation readout expected in 2027.

The Power Play: Why a $1.45 Billion Raleigh Acquisition Is Really About AI's Bottleneck

Vertiv is buying Raleigh's UtilityInnovation Group for $1.45 billion in cash, with earnouts that could push the price to $2.6 billion. The deal says more about the AI boom's real constraint than about any single company.

NEXT Earnouts to $2.6B hinge on grid-interactive software, the piece of the AI stack North Carolina actually makes.